^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

CDX-2 overexpression

i
Other names: CDX-3/AS, CDX3, CDX2, Caudal type homeobox 2
Entrez ID:
Related biomarkers:
9ms
Clinicopathologic and Molecular Characterization of Anorectal Neuroendocrine Carcinomas Reveals Human Papillomavirus, p53 and c-Myc as Alternative Mechanisms of Carcinogenesis. (PubMed, Mod Pathol)
Our study demonstrates that anorectal NECs arise in HPV-dependent or independent pathways, with heterogeneous expression of other lineage markers and different molecular signatures. Expression of p53 and c-Myc proteins appear to be mutually exclusive regardless of HPV status, likely mediating alternative mechanisms of NEC carcinogenesis.
Journal
|
TP53 (Tumor protein P53) • MYC (V-myc avian myelocytomatosis viral oncogene homolog) • CDX2 (Caudal Type Homeobox 2) • TP63 (Tumor protein 63)
|
MYC amplification • MYC expression • TP53 overexpression • CDX-2 overexpression
10ms
Resveratrol induces the growth inhibition of CDX-deficient gastric cancer cells using CDX2 and RUNX3 via the β-catenin/TCF4 signaling pathway. (PubMed, Transl Oncol)
Upon treatment with lithium chloride (LiCl), the proliferation, migration, and invasion of CDX2-overexpressing MKN7 and TMK1 cells were enhanced. Our results indicate that Res inhibits the growth of MKN7 and TMK1 cells by increasing RUNX3 and CDX2 expression levels, with the potential involvement of the β-catenin/TCF-4 signaling pathway.
Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • TCF3 (Transcription Factor 3) • BAX (BCL2-associated X protein) • CDX2 (Caudal Type Homeobox 2) • RUNX3 (RUNX Family Transcription Factor 3) • TCF4 (Transcription Factor 4)
|
BAX expression • CDX-2 expression • CDX-2 overexpression
over2years
Transcription factor CDX2 up-regulates proto-oncogenic miR-744 via a promoter activation mechanism in non-small-cell lung cancer. (PubMed, Ann Transl Med)
CDX2-induced up-regulation of miR-744 can significantly promote the migration and invasion of NSCLC cells, while overexpression CDX2 is sufficient to rescue the migration and invasion capacity of these cells following knockdown of miR-744. In summary, our results confirmed for the first time the regulatory mechanism of CDX2 on miR-744 transcription and provided a potential mechanism for CDX2 as an oncogene in lung cancer.
Journal
|
CDX2 (Caudal Type Homeobox 2)
|
CDX-2 overexpression
almost3years
CDX2 and Reg IV expression and correlation in gastric cancer. (PubMed, BMC Gastroenterol)
Our findings demonstrate that CDX2 expression was positively correlated with that of Reg IV in gastric cancer, and CDX2 promoted cell migration and invasion through upregulation of Reg IV expression in AGS and MKN-45 cells.
Journal
|
SOX9 (SRY-Box Transcription Factor 9) • CDX2 (Caudal Type Homeobox 2)
|
CDX-2 expression • CDX-2 overexpression • SOX9 expression